Intratumoral injection of interferon gamma promotes the efficacy of anti-PD1 treatment in colorectal cancer
Cancer Letters · 2024-04 · 588 · 216798
DOI: 10.1016/j.canlet.2024.216798 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024-04. Verfasst von Yang Tang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Labora…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Colorectal Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Immune checkpoint inhibitors (ICIs) offer new options for the treatment of patients with solid cancers worldwide. The majority of colorectal cancers (CRC) are proficient in mismatch-repair (pMMR) genes, harboring fewer tumor antigens and are insensitive to ICIs. These tumors are often found to be immune-deserted. We hypothesized that forcing immune cell infiltration into the tumor microenvironment followed by immune ignition by PD1 blockade may initiate a positive immune cycle that can boost antitumor immunity. Bioinformatics using a public database suggested that IFNγ was a key indicator of immune status and prognosis in CRC. Intratumoral administration of IFNγ increased immune cells infiltration into the tumor, but induced PD-L1 expression. A combined treatment strategy using IFNγ and anti-PD-1 antibody significantly increased T cell killing of tumor cells in vitro and showed synergistic inhibition of tumor growth in a mouse model of CRC. CyTOF found drastic changes in the immune microenvironment upon combined immunotherapy. Treatment with IFNγ and anti-PD1 antibody in CT26 tumors significantly increased infiltration of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs). IFNγ had a more pronounced effect in decreasing intratumoral M2-like macrophages, while PD1 blockade increased the population of CD8+Ly6C + T cells in the tumor microenvironment, creating a more pro-inflammatory microenvironment. Additionally, PD1 induced increased expression of lymphocyte activating 3 (LAG3) in a significant fraction of CD8+ T cells and Treg cells, indicating potential drug resistance and feedback mechanisms. In conclusion, our work provides preclinical data for the Combined immunotherapy of CRC using intratumoral delivery of IFNγ and systemic anti-PD1 monoclonoal antibody.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Colorectal Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, Chin…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Tang, Y., Wei, J., Ge, X., Yu, C., Lu, W., Qian, Y., Yang, H., Fu, D., Fang, Y., Zhou, X., Wang, Z., Xiao, Q., & Ding, K. (2024). Intratumoral injection of interferon gamma promotes the efficacy of anti-PD1 treatment in colorectal cancer. Cancer Letters, 588, 216798. https://doi.org/10.1016/j.canlet.2024.216798
Vancouver
Tang Y, Wei J, Ge X, Yu C, Lu W, Qian Y, et al. Intratumoral injection of interferon gamma promotes the efficacy of anti-PD1 treatment in colorectal cancer. Cancer Letters. 2024;588:216798. doi:10.1016/j.canlet.2024.216798
BibTeX
@article{Tang2024,
author = {Tang, Yang and Wei, Jingsun and Ge, Xiaoxu and Yu, Chengxuan and Lu, Wei and Qian, Yucheng and Yang, Hang and Fu, Dongliang and Fang, Yimin and Zhou, Xinyi and Wang, Zhanhuai and Xiao, Qian and Ding, Kefeng},
title = {Intratumoral injection of interferon gamma promotes the efficacy of anti-PD1 treatment in colorectal cancer},
journal = {Cancer Letters},
year = {2024},
volume = {588},
pages = {216798},
doi = {10.1016/j.canlet.2024.216798}
}
EUVIMED